Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,967.38
(
1.18%
)
US TECH 100
25,156.80
(
0.05%
)
Dow Jones
48,535.99
(
0.66%
)
Brent Oil
93.02
(
-2.57%
)
Bitcoin
73,990.08
(
-0.29%
)
News Focus
News Focus

Replies to post #496128 on $Stock*Shop*Charts*News*Option$

Replies to #496128 on $Stock*Shop*Charts*News*Option$
icon url

Tuff-Stuff

01/30/13 8:45 AM

#496129 RE: Tuff-Stuff #496128

Abbott Labs spin-off AbbVie (ABBV) forecasts 2013 earnings in line with consensus, predicting adjusted EPS of $3.03-$3.13 vs estimates of $3.08. AbbVie expects its growth to be driven by new treatments for illnesses that have a high unmet need.